BioNexus Gene Lab Corp (BGLC)
0.595
-0.01
(-1.49%)
USD |
NASDAQ |
May 06, 16:00
0.595
0.00 (0.00%)
After-Hours: 20:00
BioNexus Gene Lab Revenue (TTM): 9.771M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 9.771M |
| September 30, 2023 | 10.34M |
| June 30, 2023 | 10.36M |
| March 31, 2023 | 10.28M |
| December 31, 2022 | 10.93M |
| September 30, 2022 | 11.33M |
| June 30, 2022 | 12.34M |
| March 31, 2022 | 12.94M |
| December 31, 2021 | 13.36M |
| Date | Value |
|---|---|
| September 30, 2021 | 14.24M |
| June 30, 2021 | 13.76M |
| March 31, 2021 | 11.77M |
| December 31, 2020 | 11.39M |
| September 30, 2020 | 7.318M |
| June 30, 2020 | 4.251M |
| March 31, 2020 | 3.169M |
| December 31, 2019 | 0.127M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
0.127M
Minimum
Dec 2019
14.24M
Maximum
Sep 2021
9.863M
Average
10.93M
Median
Dec 2022
Revenue (TTM) Benchmarks
| Balchem Corp | 922.44M |
| Friedman Industries Inc | 508.20M |
| Solitario Resources Corp | -- |
| Golden Minerals Co | 12.00M |
| Paramount Gold Nevada Corp | -- |